Aarti Industries LtdQ4 FY25

Aarti Industries Ltd Q4 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: 534P/E: 33.8Market Cap: ₹17.6K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2
  • Company targets sustainable mid- to long-term growth with 20%-25% CAGR EBITDA over 3-5 years.
  • Volumes in non-energy business grew by 14% YoY and 8% QoQ; energy business grew 10% QoQ, with a potential upside delayed by shipment timing.
  • MMA production volume has grown significantly, from 59 kt to 88 kt in 9 months YoY.
  • Base business volume gains are a priority; utilization rates expected to ramp up to 80%+ in PNCB chain, supporting volume growth.
  • New business in MMA is scaling up through strategic customers in US, Middle East, and efforts in Europe and Southeast Asia.
  • Growth in exports stable around INR1,000 crore quarter-to-quarter despite MMA volume growth due to shipment timing.
  • Expansion projects (e.g., Zone IV, specialty chemicals) and new JV initiatives (plastic recycling) aimed to drive future revenue growth.
  • Pricing pressures expected to stabilize with product mix optimization supporting margin and volume growth in upcoming quarters.

Margin guidance

Category 3
  • Aarti Industries targets a sustainable mid-to-long-term EBITDA growth of roughly 20%-25% CAGR over 3 to 5 years.
  • The company aims for EBITDA in the range of INR1,800 crore to INR2,200 crore within 3 years, targeting EBITDA margins around 14%-15%.
  • ROCE and ROIC are expected to improve to the range of 14%-15% as per the mid-term guidance.
  • Efforts to enhance asset utilization and optimize product mix are expected to improve margin profiles going forward.
  • Incremental volumes, especially in MMA business, and expansion projects like Zone IV greenfield and nitrotoluene capacity increase will drive growth.
  • Cost reduction initiatives targeting INR150-200 crore savings over 12-18 months will support operating efficiencies.
  • Long-term forex and rupee depreciation are expected to benefit the net exporter structurally despite short-term MTM volatility.
  • Overall, management is confident about achieving ROCE and EBITDA growth targets with ongoing capacity expansions and market diversification.

3 more insights locked — sign up free to unlock

Fundraise plans

  • The transcript does not mention any immediate or planned fundraising through new debt or equity issuance.
  • Existing debt includes an ECB loan of around $140 million, largely unhedged, with a repayment tenure of approximately 9 years.
  • Capex guidance for FY25 is INR1,300 to INR1,500 crore, tapering to below INR1,000 crore in FY26, to be funded presumably through internal accruals and existing financial resources.
  • No direct references to new equity fundraising or additional debt plans were provided during the call.
  • The company appears focused on optimizing existing assets and deploying capital for capacity expansions and new projects within guided capex limits.

Order book

  • The transcript provided does not explicitly mention details about the current or expected order book or pending orders for Aarti Industries Limited.
  • However, references to volume-led recovery and new customer additions in MMA business suggest ongoing demand.
  • The company is focused on expanding its client base globally and scaling up MMA production (noted production growth from 59 kt to 88 kt Y-o-Y for 9 months).
  • Bulk shipments and inventory build-ups indicate active order fulfillment and preparation for future demand.
  • Emphasis on entering newer business opportunities and optimizing assets hints at expected order flow growth.
  • For precise current or expected order book figures, direct investor relations contact is recommended as per closing remarks.

Capex plans

Yes
  • FY25 capex guidance remains INR1,300 to INR1,500 crore; 9-month spend about INR1,020 crore (Page 4, 12).
  • FY26 capex expected to be below INR1,000 crore, with tapering from FY25 levels (Page 12).
  • Zone IV expansion (new greenfield site) being executed in phases; commissioning expected gradually through FY26; pilot plant already operational (Pages 4,16).
  • Zone IV designed for flexible multi-purpose production, enabling margin optimization (Page 16).
  • MMA capacity expanded to 200 KTPA, with potential for further minor expansions as needed (Page 4).
  • Investment of INR100 crore (INR50 crore each partner) committed in a joint venture for specialty chemicals (Page 16).
  • Plastic recycling JV with RESL for advanced chemical recycling targeting 100 TPD in 18 months and 500 TPD by 2030; detailed revenue/EBITDA potential forthcoming (Page 7).
  • Renewable energy investments via power purchase agreements aiming for >75% renewable share by Q1 FY27 (Page 4,17).

How does Aarti Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature
1Aarti Industries Ltd
Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Aarti Industries Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio